Biosimilars: balancing access to affordable medicines with safety
3 November 2017
Biological medicines (biologics) are agents derived from a biological source.
Read on
patents
Here’s the drill: The Full Federal Court clarifies the requirement that patents disclose the ‘best method’ of performing the invention
27 September 2017
The Full Federal Court recently drilled down on the ‘best method’ requirement in Australia in Sandvik Intellectual Property AB v Quarry Mining & Construction Equipment Pty Ltd [2017] FCAFC 138.
Read on
Threats Muddy Waters: unjustified threats of infringement in the Full Federal Court of Australia
26 May 2017
A decision in March of the Full Federal Court in Australian Mud Company Pty Ltd v Coretell Pty Ltd [2017] FCAFC 44 concerning unjustified threats of infringement will have some lawyers as happy as pigs in mud.
Read on
‘Essential’ telecom patents: How to win FRANDs and influence people
4 May 2017
The UK High Court’s 150+ page epic on fair, reasonable and non-discriminatory (FRAND) licence terms in Unwired Planet v Huawei has stirred up a lot of commentary in the tech nerd space and the international patent community (across which there is probably a fair bit of overlap).
Read on
Off to a running start? Federal Court of Australia permits generic manufacturer to make PBS application before patent expiry
28 April 2017
Can a manufacturer apply for Pharmaceutical Benefits Scheme (PBS) approval for a generic drug before the patent has expired?
Read on
Big data, big risk – investing in a “largely theoretical” industry
24 February 2017
Between 31 May 2012 and 26 March 2013, an Australian husband and wife (Mr and Ms Vinson), through their self-managed superannuation funds, invested $1,250,000 and $1,625,000 respectively in a company that never earned any operating revenue.
Read on
Don’t you wanna dance with me? US Supreme Court to hear Amgen v Sandoz biosimilars case
24 January 2017
The US Supreme Court has granted petitions for certiorari in Amgen v.
Read on
Productivity Commission’s final report pulls no punches on patents
21 December 2016
Yesterday the Productivity Commission published its final report on Australia’s IP system.
Read on
Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)
26 August 2016
On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates’ findings that Otsuka’s patent relating to aripiprazole, a drug used in the treatment of schizophrenia, is invalid for want of novelty and inventive step.
Read on
Productivity Commission recommends extensive changes to Australian IP – including fair use, circumventing geoblocks, abolishing business method and software patents and more!
29 April 2016
Today, the Productivity Commission has released its draft report into Australia’s intellectual property arrangements.
Read on
Load More Posts